首頁 > 市場調查報告書 > 醫療設備

心血管設備

市場調查報告書

商品編碼

1667938

分叉病變市場 - 全球產業規模、佔有率、趨勢、機會和預測，按應用細分（周邊、冠狀動脈）、按地區、競爭情況，2020-2030 年預測

Bifurcation Lesions Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, Segmented By Application (Peripheral, Coronary), By Region, Competition, 2020-2030F

出版日期: 2025年02月28日 | 出版商:

TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2024 年全球分叉病變市場價值為 27.6 億美元，預計到 2030 年將達到 40.2 億美元，複合年成長率為 6.43%。

市場概況
預測期	2026-2030
2024 年市場規模	27.6 億美元
2030 年市場規模	40.2 億美元
2025-2030 年複合年成長率	6.43%
成長最快的領域	周邊設備
最大的市場	北美洲

全球分叉病變市場涉及醫療設備、程序和療法，旨在解決血管（特別是冠狀動脈）分叉病變的挑戰。這些病變會限制血流，導致心血管併發症。

主要市場促進因素

心血管疾病盛行率上升

主要市場挑戰

分叉病變治療的複雜性

監管和報銷障礙

Global Bifurcation Lesions Market was valued at USD 2.76 billion in 2024 and is expected to reach USD 4.02 Billion in the forecast period with a CAGR of 6.43% through 2030. The Global Bifurcation Lesions Market encompasses a specialized segment of the medical industry focused on the diagnosis and treatment of bifurcation lesions, which occur when a major artery divides into two smaller branches.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 2.76 Billion
Market Size 2030	USD 4.02 Billion
CAGR 2025-2030	6.43%
Fastest Growing Segment	Peripheral
Largest Market	North America

The Global Bifurcation Lesions Market deals with medical devices, procedures, and therapies aimed at addressing the challenges posed by bifurcation lesions in blood vessels, particularly in coronary arteries. These lesions can restrict blood flow, leading to cardiovascular complications.

Key Market Drivers

Increasing Cardiovascular Disease Prevalence

The increasing prevalence of cardiovascular diseases (CVDs) serves as a significant market driver propelling the growth of the Global Bifurcation Lesions Market. Cardiovascular diseases, encompassing conditions like coronary artery disease, heart attacks, and angina, are a leading cause of morbidity and mortality globally. The World Health Organization (WHO) reports that CVDs are responsible for over 17 million deaths annually, making them the leading cause of death worldwide. As lifestyles become more sedentary, diets less healthy, and populations age, the burden of CVDs is projected to continue increasing. Bifurcation lesions are a subset of cardiovascular conditions in which plaque buildup or blockages occur at the junctions where major arteries split into smaller branches. Such lesions can lead to severe complications, including heart attacks and reduced blood flow to vital organs. As the prevalence of CVDs increases, so does the incidence of bifurcation lesions, driving the demand for specialized treatments. According to Centers for Disease Control and Prevention, Heart disease is the leading cause of death for both men and women, as well as for individuals across most racial and ethnic groups. Every 33 seconds, someone dies from cardiovascular disease. In 2022 alone, heart disease was responsible for 702,880 deaths, accounting for roughly one in every five deaths.

Key Market Challenges

Complexity of Bifurcation Lesion Treatment

Bifurcation lesions pose a unique set of challenges due to the branching of blood vessels. These complexities include variable lesion morphologies, side branch ostial stenosis, and the risk of restenosis at the bifurcation point. Treating these lesions requires specialized techniques, tools, and stents, which can be challenging for healthcare providers. Additionally, the need for expert knowledge and training in bifurcation lesion management can limit the number of physicians who can effectively perform these procedures, potentially slowing down market growth.

Regulatory and Reimbursement Hurdles

Medical devices and procedures in the cardiovascular field, including those used for bifurcation lesion treatment, are subject to stringent regulatory requirements and approvals. Obtaining regulatory clearance or approval can be a time-consuming and costly process. Furthermore, reimbursement policies vary by region, and reimbursement challenges can affect the adoption of newer and more advanced technologies. Limited or delayed reimbursement for these procedures can discourage healthcare providers from offering them, which can hinder market expansion.

Key Market Players

Boston Scientific Corp.
Abbott Laboratories Inc.
Cardinal Health Inc.
Medtronic Plc
C. R. Bard, Inc (Becton, Dickinson and Company)
Johnson & Johnson Services, Inc.
Spectranetics Corp (Philips Healthcare)
Terumo Medical Corp.
Poseidon Medical Inc

Report Scope:

In this report, the Global Bifurcation Lesions Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Bifurcation Lesions Market, By Application:

Peripheral
Coronary

Bifurcation Lesions Market, By Region:

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
- Turkey
- Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Bifurcation Lesions Market.

Available Customizations:

Global Bifurcation Lesions market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Bifurcation Lesions Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Application (Peripheral, Coronary)
- 5.2.2. By Region
- 5.2.3. By Company (2024)
5.3. Market Map

6. North America Bifurcation Lesions Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Application
- 6.2.2. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Bifurcation Lesions Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Application
- 6.3.2. Canada Bifurcation Lesions Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Application
- 6.3.3. Mexico Bifurcation Lesions Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Application

7. Europe Bifurcation Lesions Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Application
- 7.2.2. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Bifurcation Lesions Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Application
- 7.3.2. United Kingdom Bifurcation Lesions Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Application
- 7.3.3. Italy Bifurcation Lesions Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Application
- 7.3.4. France Bifurcation Lesions Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Application
- 7.3.5. Spain Bifurcation Lesions Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Application

8. Asia-Pacific Bifurcation Lesions Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Application
- 8.2.2. By Country
8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Bifurcation Lesions Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Application
- 8.3.2. India Bifurcation Lesions Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Application
- 8.3.3. Japan Bifurcation Lesions Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Application
- 8.3.4. South Korea Bifurcation Lesions Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Application
- 8.3.5. Australia Bifurcation Lesions Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Application

9. South America Bifurcation Lesions Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Application
- 9.2.2. By Country
9.3. South America: Country Analysis
- 9.3.1. Brazil Bifurcation Lesions Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Application
- 9.3.2. Argentina Bifurcation Lesions Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Application
- 9.3.3. Colombia Bifurcation Lesions Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Application

10. Middle East and Africa Bifurcation Lesions Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Application
- 10.2.2. By Country
10.3. MEA: Country Analysis
- 10.3.1. South Africa Bifurcation Lesions Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Application
- 10.3.2. Saudi Arabia Bifurcation Lesions Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Application
- 10.3.3. UAE Bifurcation Lesions Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Application
- 10.3.4. Kuwait Bifurcation Lesions Market Outlook
  - 10.3.4.1. Market Size & Forecast
    - 10.3.4.1.1. By Value
  - 10.3.4.2. Market Share & Forecast
    - 10.3.4.2.1. By Application
- 10.3.5. Turkey Bifurcation Lesions Market Outlook
  - 10.3.5.1. Market Size & Forecast
    - 10.3.5.1.1. By Value
  - 10.3.5.2. Market Share & Forecast
    - 10.3.5.2.1. By Application
- 10.3.6. Egypt Bifurcation Lesions Market Outlook
  - 10.3.6.1. Market Size & Forecast
    - 10.3.6.1.1. By Value
  - 10.3.6.2. Market Share & Forecast
    - 10.3.6.2.1. By Application

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Recent Developments
12.2. Product Launches
12.3. Mergers & Acquisitions

13. Global Bifurcation Lesions Market: SWOT Analysis

14. Competitive Landscape

14.1. Boston Scientific Corp.
- 14.1.1. Business Overview
- 14.1.2. Product & Service Offerings
- 14.1.3. Recent Developments
- 14.1.4. Key Personnel
- 14.1.5. SWOT Analysis
- 14.1.6. Financials (As Reported)
14.2. Abbott Laboratories Inc.
14.3. Cardinal Health Inc.
14.4. Medtronic Plc
14.5. C. R. Bard, Inc.(Becton, Dickinson and Company)
14.6. Johnson & Johnson Services, Inc.
14.7. Spectranetics Corp (Philips Healthcare)
14.8. Terumo Medical Corp.
14.9. Poseidon Medical Inc.